Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,146 public trials 6,477 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

NCT06656494

Conditions
Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • NYU Langone Health New York, United States
  • St Vincent's Hospital Sydney, New South Wales, Australia
  • Royal Perth Hospital Perth, Western Australia, Australia
View all 22 locations
View Trial Details
Recruiting

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

NCT06966024

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • Vanderbilt- Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Recruiting

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

NCT04485559

Conditions
Glioma, High-Grade Glioma (HGG), Low-grade Glioma, +8 more
Locations
  • University of Alabama at Birmingham, Children's of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California, San Diego Rady Children's Hospital San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 17 locations
View Trial Details
Recruiting

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

NCT07422610

Conditions
Advanced Malignancies and Hepatic Impairment, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Saint-Herblain, France
  • Novartis Investigative Site Candiolo, TO, Italy
  • Novartis Investigative Site Pozuelo de Alarcón, Madrid, Spain
View Trial Details
Recruiting

Same-day Radioembolization for Large HCC

NCT06944483

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • National Cancer Center Goyang, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
  • Severance hospital Seoul, South Korea
View Trial Details
Recruiting

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

NCT07182149

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Normunity Investigational Site Denver, Colorado, United States
  • Normunity Investigational Site New Haven, Connecticut, United States
  • Normunity Investigational Site Minneapolis, Minnesota, United States
  • Normunity Investigational Site Maumee, Ohio, United States
View all 18 locations
View Trial Details

Related conditions